If you have Nebula Genomics whole genome sequencing data, you're holding one of the most complete genetic datasets a consumer can own. Unlike genotyping chips from 23andMe or AncestryDNA — which look at hundreds of thousands of pre-selected positions — whole genome sequencing reads essentially every base in your genome. That means your Nebula VCF file contains every clinically relevant pharmacogenetic variant, including rare ones that genotyping chips miss entirely. A pharmacogenetic report built from WGS data can be more thorough than reports based on SNP arrays.
Pharmacogenetic information is a decision-support tool, not a medical directive. Do not change, stop, or start any medication based on a pharmacogenetic report alone. Always consult your prescribing clinician.
Clinical pharmacogenetics relies on identifying star alleles (e.g., CYP2D6*4, CYP2C19*2) that define metabolizer phenotypes. Genotyping arrays only test specific pre-designed positions, so rare or less-studied star alleles can be missed. Whole genome sequencing reads every base, so the entire star allele catalog is visible — including variants your clinician or pharmacist may want to know about.
Nebula Genomics has historically offered optional health reports, but its drug response interpretation has been limited and has changed over time. Many Nebula users find themselves with a rich VCF file and no easy way to get a comprehensive pharmacogenetic interpretation from it. That's the gap a dedicated PGx service fills.
Whole genome sequencing only needs to be done once. Your VCF file never expires — your DNA is the same today as it was the day Nebula sent you the results. Running that same file through new or updated pharmacogenetic analyses in the future costs nothing extra in lab work.
A whole genome sequence already costs more than most clinical PGx panels. If you've already paid for Nebula sequencing, paying again for a separate clinical pharmacogenetic test is redundant. Analyzing your existing VCF delivers the same — often more detailed — information at a fraction of the price.
Pharmacogenetic analysis of a Nebula WGS VCF reveals variants across the full set of clinically actionable pharmacogenes, not just the common ones.
Metabolizes about 25% of prescribed drugs including many antidepressants, opioids (codeine, tramadol), atomoxetine, tamoxifen, and beta-blockers. CYP2D6 is notoriously complex due to copy number variation and pseudogenes — WGS helps resolve alleles that genotyping arrays sometimes call incorrectly.
Affects SSRIs, clopidogrel, and proton pump inhibitors. WGS picks up rare CYP2C19 alleles like *17 (ultrarapid) and less common loss-of-function variants.
Critical for fluoropyrimidine chemotherapy safety (fluorouracil, capecitabine). DPYD variants can cause life-threatening toxicity at standard doses. Rare variants are more easily detected in WGS than on a SNP chip.
Determines safe dosing of thiopurine drugs (azathioprine, mercaptopurine, thioguanine). Poor metabolizers can develop severe bone marrow suppression at standard doses.
HLA-B*57:01 carriers have a high risk of severe hypersensitivity to abacavir; HLA-B*15:02 carriers can develop Stevens-Johnson syndrome from carbamazepine. WGS is particularly valuable for HLA allele calling.
Drives statin-associated muscle pain risk. Important for anyone taking or considering a statin.
WGS-based pharmacogenetic reports assign metabolizer phenotypes with more confidence than genotyping-based reports because more of the relevant variation is directly observed rather than imputed. The output is the same structure — metabolizer status plus drug-by-drug recommendations based on CPIC and FDA guidelines — but the underlying evidence is stronger.
Converting your Nebula VCF into a pharmacogenetic report is worthwhile for anyone on long-term medications, anyone starting a new prescription with PGx guidelines, and anyone who has experienced unexplained side effects or non-response to a drug. Because your WGS data does not change, the analysis is a one-time step with lifelong value.
Learn how genetics may affect your response to these related medications:
Nebula has offered limited drug-related insights through its reports over time, but these have not provided the comprehensive CPIC-based interpretation that a dedicated pharmacogenetic service delivers. Running your VCF through Gene2Rx gives a structured, guideline-aligned PGx report.
For most common pharmacogenetic variants, high-quality genotyping is very accurate. WGS adds value for rare alleles and for genes with structural complexity like CYP2D6 and HLA, where genotyping chips can miss or miscall variants.
Standard bgzipped (.vcf.gz) VCF files aligned to GRCh37 (hg19) or GRCh38 (hg38) are supported. If your Nebula export is unusual, Gene2Rx's documentation lists the supported file formats.
Yes. Your VCF is permanent raw data. As CPIC and FDA pharmacogenetic guidelines evolve, you can regenerate an updated report from the same file without needing any new sequencing.
Find out how your DNA may influence your response to Sertraline and other medications with a Gene2Rx pharmacogenetics report.
Get Your Report Try Our Free Calculator